1.046EUR+11.28%Mkt Cap: 69.50M EURP/E: —Last update: 2026-05-14
AB Science S.A., a clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cance…
Industry Peers
Drug Manufacturers - Specialty & Generic153.14BSEKP/E 167.7
58.14BTRYP/E 27.8
51.02BEURP/E 20.1
13.68BEURP/E 31.2
13.35BTRY—
13.10BSEKP/E 39.5
3.09BTRY—
3.02BEURP/E 25.0
loading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-7.11
PEG—
P/B-2.42
P/S59.20
EV/EBITDA—
EV/Revenue—
EPS (TTM)-0.15
EPS (Forward)-0.14
Cash Flow & Leverage
FCF Yield—
FCF Margin—
Operating CF525.00K EUR
CapEx (TTM)155.00K EUR
Net Debt/EBITDA—
Net Debt—
Technical
SMA 501.156 (-9.5%)
SMA 2001.253 (-16.5%)
Beta—
S&P 52W Chg24.23%
Avg Vol (30d)242.14K
Avg Vol (10d)390.32K
Technical Indicators
RSI (14)44.9
MACD-0.0590
MACD Signal-0.0544
MACD Hist.-0.0046
BB Upper1.263 EUR
BB Middle1.077 EUR
BB Lower0.8907 EUR
BB Width34.55%
ATR (14)0.0518 EUR
Vol Ratio (20d)1.41x
52W Range
0.930015% of range1.730
52W High1.730 EUR
52W Low0.9300 EUR
Profitability
Gross Margin116.42%
EBITDA Margin87.99%
Profit Margin-730.50%
Oper. Margin510.93%
ROE32.97%
ROA-33.79%
Revenue Growth28.70%
Earnings Growth—
Balance Sheet
Debt/Equity-0.78
Current Ratio—
Quick Ratio—
Book Value/Sh-0.4110 EUR
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.69.78M
Float18.68M
Insiders29.22%
Institutions0.00%
Analyst Consensus
Rating—
Target (Mean)5.170 EUR
Target Range5.170 EUR – 5.170 EUR
# Analysts1
Company
Market Cap69.50M EUR
Enterprise Value—
Revenue (TTM)1.17M EUR
Gross Profit1.25M EUR
Net Income (TTM)-7.83M EUR
Revenue/Share0.0230 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
Last Price1.046 EUR
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINFR0010557264